checkAd

     197  0 Kommentare Protolabs Reports Financial Results for the Third Quarter of 2021

    Proto Labs, Inc. (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the third quarter ended September 30, 2021.

    Third Quarter 2021 Highlights include:

    • Revenue for the third quarter of 2021 was $125.3 million, representing a 16.6 percent increase compared to revenue of $107.5 million in the third quarter of 2020.
    • Hubs generated $8.8 million of revenue in the third quarter.
    • Net income for the third quarter of 2021 was $4.8 million, or $0.17 per diluted share.
    • Non-GAAP net income was $9.7 million, or $0.35 per diluted share. See “Non-GAAP Financial Measures” below.

    “We achieved record revenue in the third quarter amidst a difficult backdrop of global supply chain issues and labor and materials constraints. During the quarter, we also received external recognition of our best-in-class digital manufacturing capabilities as the World Economic Forum announced our induction into their Global Lighthouse Network, recognizing our industry leading efforts to implement Fourth Industrial Revolution technologies,” noted Rob Bodor, President and Chief Executive Officer. “We continue to focus on the long-term market opportunities and invest in the business to serve the evolving needs of our customers.”

    Additional Third Quarter 2021 Highlights include:

    • Protolabs served 23,457 unique product developers during the quarter, representing a 24.8 percent increase over the third quarter of 2020.
    • Gross margin in the third quarter of 2021 was 44.1 percent of revenue; Non-GAAP gross margin was 44.9 percent of revenue. See “Non-GAAP Financial Measures” below.
    • EBITDA margin was 13.7 percent of revenue in the third quarter of 2021; adjusted EBITDA margin was 17.1 percent of revenue in the third quarter of 2021. See “Non-GAAP Financial Measures” below.
    • Cash and investments balance was $83.9 million as of September 30, 2021.

    “Our earnings in the third quarter were impacted by post pandemic-related cost inflation, as well as continued investments in our systems and product offering in order to maintain our position as the largest and fastest provider of digital manufacturing services,” added John Way, Chief Financial Officer. “We have a very strong balance sheet with $84 million in cash and investments and no debt, allowing us to continue to invest in future growth and return capital to our shareholders.”

    Non-GAAP Financial Measures

    The company has included non-GAAP revenue growth that excludes the impact of changes in foreign currency exchange rates and revenue earned from our acquisition of Hubs (collectively, “non-GAAP revenue growth”). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.

    The company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, and transaction costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the company’s financial results.

    The company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, and transaction costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the company’s financial results.

    The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, and transaction costs (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the company’s financial results.

    The company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP operating margin, non-GAAP revenue growth and Adjusted EBITDA, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company’s business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

    Conference Call

    The company has scheduled a conference call to discuss its third quarter 2021 financial results and fourth quarter 2021 outlook today, October 28, 2021 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/kff4bprd. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

    About Protolabs

    Protolabs is the world’s leading provider of digital manufacturing services. The e-commerce-based company offers injection molding, CNC machining, 3D printing, and sheet metal fabrication to product developers, engineers, and supply chain teams across the globe. Protolabs serves customers using in-house production capabilities that bring unprecedented speed in tandem with Hubs, a Protolabs Company, which serves customers through its network of premium manufacturing partners. Together, they help companies bring new ideas to market with the fastest and most comprehensive digital manufacturing service in the world. Visit protolabs.com for more information.

    Forward-Looking Statements

    Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

     
    Proto Labs, Inc.
    Condensed Consolidated Balance Sheets
    (In thousands)
     
     
    September 30, December 31,

    2021

    2020

    (Unaudited)
    Assets
    Current assets
    Cash and cash equivalents

    $

    47,802

    $

    127,603

    Short-term marketable securities

     

    16,542

     

    34,088

    Accounts receivable, net

     

    85,629

     

    57,877

    Inventory

     

    9,813

     

    10,862

    Income taxes receivable

     

    1,766

     

    540

    Prepaid expenses and other current assets

     

    10,571

     

    11,032

    Total current assets

     

    172,123

     

    242,002

     
    Property and equipment, net

     

    283,019

     

    282,666

    Goodwill

     

    404,240

     

    128,752

    Other intangible assets, net

     

    39,816

     

    14,350

    Long-term marketable securities

     

    19,557

     

    59,357

    Operating lease assets

     

    5,197

     

    9,855

    Finance lease assets

     

    2,022

     

    2,396

    Other long-term assets

     

    4,337

     

    4,826

    Total assets

    $

    930,311

    $

    744,204

     
    Liabilities and shareholders' equity
    Current liabilities
    Accounts payable

    $

    22,735

    $

    18,248

    Accrued compensation

     

    15,269

     

    11,989

    Accrued liabilities and other

     

    12,636

     

    16,193

    Current contingent consideration

     

    2,506

     

    -

    Current operating lease liabilities

     

    2,362

     

    3,272

    Current finance lease liabilities

     

    555

     

    552

    Total current liabilities

     

    56,063

     

    50,254

     
    Long-term contingent consideration

     

    2,294

     

    -

    Long-term operating lease liabilities

     

    2,792

     

    7,586

    Long-term finance lease liabilities

     

    1,498

     

    1,919

    Long-term deferred tax liabilities

     

    36,331

     

    33,854

    Other long-term liabilities

     

    6,712

     

    6,235

     
    Shareholders' equity

     

    824,621

     

    644,356

    Total liabilities and shareholders' equity

    $

    930,311

    $

    744,204

     

    Proto Labs, Inc.

    Condensed Consolidated Statements of Operations
    (In thousands, except share and per share amounts)
    (Unaudited)
           
    Three Months Ended   Nine Months Ended
    September 30,   September 30,

     

    2021

     

     

    2020

     

     

    2021

     

     

    2020

    Revenue      
    Injection Molding

    $

    57,685

     

    $

    53,257

     

    $

    172,212

     

    $

    165,927

    CNC Machining

     

    43,658

     

     

    33,115

     

     

    121,953

     

     

    99,760

    3D Printing

     

    18,589

     

     

    16,294

     

     

    53,994

     

     

    46,478

    Sheet Metal

     

    4,854

     

     

    3,988

     

     

    14,790

     

     

    14,306

    Other

     

    556

     

     

    850

     

     

    1,567

     

     

    2,716

    Total revenue

     

    125,342

     

     

    107,504

     

     

    364,516

     

     

    329,187

           
    Cost of revenue

     

    70,018

     

     

    52,861

     

     

    197,237

     

     

    163,988

    Gross profit

     

    55,324

     

     

    54,643

     

     

    167,279

     

     

    165,199

           
    Operating expenses      
    Marketing and sales

     

    21,422

     

     

    16,705

     

     

    61,946

     

     

    51,821

    Research and development

     

    10,614

     

     

    7,915

     

     

    33,855

     

     

    25,550

    General and administrative

     

    16,361

     

     

    12,354

     

     

    44,186

     

     

    38,983

    Total operating expenses

     

    48,397

     

     

    36,974

     

     

    139,987

     

     

    116,354

    Income from operations

     

    6,927

     

     

    17,669

     

     

    27,292

     

     

    48,845

    Other income (expense), net

     

    136

     

     

    728

     

     

    (40)

     

     

    2,549

    Income before income taxes

     

    7,063

     

     

    18,397

     

     

    27,252

     

     

    51,394

    Provision for income taxes

     

    2,228

     

     

    3,700

     

     

    5,790

     

     

    10,106

    Net income

    $

    4,835

     

    $

    14,697

     

    $

    21,462

     

    $

    41,288

           
    Net income per share:      
    Basic

    $

    0.17

     

    $

    0.55

     

    $

    0.78

     

    $

    1.54

    Diluted

    $

    0.17

     

    $

    0.55

     

    $

    0.77

     

    $

    1.54

           
    Shares used to compute net income per share:      
    Basic

     

    27,713,229

     

     

    26,736,709

     

     

    27,638,611

     

     

    26,724,715

    Diluted

     

    27,730,105

     

     

    26,886,433

     

     

    27,707,784

     

     

    26,861,647

           
    Proto Labs, Inc.
    Condensed Consolidated Statements of Cash Flows
    (In thousands)
    (Unaudited)
       
    Nine Months Ended
    September 30,

     

    2021

     

     

    2020

    Operating activities  
    Net income

    $

    21,462

     

    $

    41,288

    Adjustments to reconcile net income to net cash provided by operating activities:  
    Depreciation and amortization

     

    30,231

     

     

    23,891

    Stock-based compensation expense

     

    15,539

     

     

    10,617

    Deferred taxes

     

    (139)

     

     

    6,578

    Amortization of marketable securities

     

    374

     

     

    202

    Realized gain on available-for-sale securities

     

    (72)

     

     

    -

    Changes in fair value of contingent consideration

     

    (8,513)

     

     

    -

    Other

     

    140

     

     

    (865)

    Changes in operating assets and liabilities

     

    (26,797)

     

     

    664

    Net cash provided by operating activities

     

    32,225

     

     

    82,375

       
    Investing activities  
    Purchases of property, equipment and other capital assets

     

    (27,956)

     

     

    (40,489)

    Cash used for acquisitions, net of cash acquired

     

    (127,413)

     

     

    -

    Purchases of other assets and investments

     

    -

     

     

    (3,000)

    Purchases of marketable securities

     

    (15,159)

     

     

    (90,596)

    Proceeds from sales of marketable securities

     

    57,089

     

     

    -

    Proceeds from maturities of marketable securities

     

    15,114

     

     

    56,428

    Net cash used in investing activities

     

    (98,325)

     

     

    (77,657)

       
    Financing activities  
    Proceeds from exercises of stock options and other

     

    3,838

     

     

    5,674

    Purchases of shares withheld for tax obligations

     

    (4,209)

     

     

    (3,367)

    Repurchases of common stock

     

    (13,036)

     

     

    (14,686)

    Principal repayments of finance lease obligations

     

    (413)

     

     

    -

    Net cash used in financing activities

     

    (13,820)

     

     

    (12,379)

    Effect of exchange rate changes on cash and cash equivalents

     

    119

     

     

    690

    Net decrease in cash and cash equivalents

     

    (79,801)

     

     

    (6,971)

    Cash and cash equivalents, beginning of period

     

    127,603

     

     

    125,225

    Cash and cash equivalents, end of period

    $

    47,802

     

    $

    118,254

       
    Proto Labs, Inc.
    Reconciliation of GAAP to Non-GAAP Net Income per Share
    (In thousands, except share and per share amounts)
    (Unaudited)
         
    Three Months Ended Nine Months Ended
    September 30, September 30,

     

    2021

     

     

    2020

     

    2021

     

     

    2020

    Non-GAAP net income, adjusted for stock-based compensation expense,    
    amortization expense, unrealized (gain) loss on foreign currency and    
    transaction costs    
    GAAP net income

    $

    4,835

     

    $

    14,697

    $

    21,462

     

    $

    41,288

    Add back:    
    Stock-based compensation expense

     

    4,978

     

     

    3,945

     

    15,539

     

     

    10,617

    Amortization expense

     

    1,568

     

     

    754

     

    4,601

     

     

    2,262

    Unrealized (gain) loss on foreign currency

     

    121

     

     

    (84)

     

    341

     

     

    (1,020)

    Transaction costs 1

     

    (730)

     

     

    -

     

    (5,870)

     

     

    -

    Total adjustments 2

     

    5,937

     

     

    4,615

     

    14,611

     

     

    11,859

    Income tax benefits on adjustments 3

     

    (1,063)

     

     

    (1,368)

     

    (4,639)

     

     

    (3,030)

    Non-GAAP net income

    $

    9,709

     

    $

    17,944

    $

    31,434

     

    $

    50,117

         
         
    Non-GAAP net income per share:    
    Basic

    $

    0.35

     

    $

    0.67

    $

    1.14

     

    $

    1.88

    Diluted

    $

    0.35

     

    $

    0.67

    $

    1.13

     

    $

    1.87

         
    Shares used to compute non-GAAP net income per share:    
    Basic

     

    27,713,229

     

     

    26,736,709

     

    27,638,611

     

     

    26,724,715

    Diluted

     

    27,730,105

     

     

    26,886,433

     

    27,707,784

     

     

    26,861,647

         
         
    1 Transaction costs include direct costs incurred in our acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.
    2 Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and transaction costs were included in the following GAAP consolidated statement of operations categories:
    Three Months Ended Nine Months Ended
    September 30, September 30,

     

    2021

     

     

    2020

     

    2021

     

     

    2020

         
    Cost of revenue

    $

    986

     

    $

    989

    $

    2,974

     

    $

    2,788

         
    Marketing and sales

     

    1,059

     

     

    865

     

    2,841

     

     

    2,233

    Research and development

     

    776

     

     

    638

     

    2,144

     

     

    1,766

    General and administrative

     

    2,995

     

     

    2,207

     

    6,311

     

     

    6,092

    Total operating expenses

     

    4,830

     

     

    3,710

     

    11,296

     

     

    10,091

         
    Other (income) loss, net

     

    121

     

     

    (84)

     

    341

     

     

    (1,020)

    Total adjustments

    $

    5,937

     

    $

    4,615

    $

    14,611

     

    $

    11,859

         
    3 For the three and nine-month periods ended September 30, 2021 and 2020, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. Our non-GAAP tax rates differ from our GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.
         
    Proto Labs, Inc.
    Reconciliation of GAAP to Non-GAAP Operating Margin
    (In thousands)
    (Unaudited)
         
    Three Months Ended Nine Months Ended
    September 30, September 30,

     

    2021

     

     

    2020

     

    2021

     

     

    2020

    Revenue

    $

    125,342

     

    $

    107,504

    $

    364,516

     

    $

    329,187

    Income from operations

     

    6,927

     

     

    17,669

     

    27,292

     

     

    48,845

    GAAP operating margin

     

    5.5%

     

     

    16.4%

     

    7.5%

     

     

    14.8%

    Add back:    
    Stock-based compensation expense

     

    4,978

     

     

    3,945

     

    15,539

     

     

    10,617

    Amortization expense

     

    1,568

     

     

    754

     

    4,601

     

     

    2,262

    Transaction costs 1

     

    (730)

     

     

    -

     

    (5,870)

     

     

    -

    Total adjustments

     

    5,816

     

     

    4,699

     

    14,270

     

     

    12,879

    Non-GAAP income from operations

    $

    12,743

     

    $

    22,368

    $

    41,562

     

    $

    61,724

    Non-GAAP operating margin

     

    10.2%

     

     

    20.8%

     

    11.4%

     

     

    18.8%

         
         
    1 Transaction costs include direct costs incurred in our acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.
         
    Proto Labs, Inc.
    Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
    (In thousands)
    (Unaudited)
         
    Three Months Ended Nine Months Ended
    September 30, September 30,

     

    2021

     

     

    2020

     

    2021

     

     

    2020

    GAAP net income

    $

    4,835

     

    $

    14,697

    $

    21,462

     

    $

    41,288

    Amortization expense

     

    1,568

     

     

    754

     

    4,601

     

     

    2,262

    Depreciation expense

     

    8,536

     

     

    7,282

     

    25,630

     

     

    21,629

    Interest income, net

     

    (55)

     

     

    (255)

     

    (207)

     

     

    (1,183)

    Tax expense

     

    2,228

     

     

    3,700

     

    5,790

     

     

    10,106

    EBITDA

     

    17,112

     

     

    26,178

     

    57,276

     

     

    74,102

    Add back:    
    Stock-based compensation expense

     

    4,978

     

     

    3,945

     

    15,539

     

     

    10,617

    Unrealized (gain) loss on foreign currency

     

    121

     

     

    (84)

     

    341

     

     

    (1,020)

    Transaction costs 1

     

    (730)

     

     

    -

     

    (5,870)

     

     

    -

    Total adjustments

     

    4,369

     

     

    3,861

     

    10,010

     

     

    9,597

    Adjusted EBITDA

    $

    21,481

     

    $

    30,039

    $

    67,286

     

    $

    83,699

         
         
    1 Transaction costs include direct costs incurred in our acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.
         
                         
    Proto Labs, Inc.
    Comparison of GAAP to Non-GAAP Revenue Growth
    (In thousands)
    (Unaudited)
                         
      Three Months Ended
    September 30, 2021
        Three Months Ended
    September 30, 2020
      %      
      GAAP  

    Foreign

    Currency1

     

    Hubs

    Acquisition2

      Non-GAAP     GAAP   Change3    

    %

    Change

    Organic4

     
    Revenues                    
    United States  

    $

    100,127

     

    $

    -

     

    $

    (4,729)

     

    $

    95,398

       

    $

    85,608

     

    17.0

    %  

    11.4

    %
    Europe  

     

    22,155

     

     

    (513)

     

     

    (4,022)

     

     

    17,620

       

     

    18,897

     

    17.2

       

    (6.8)

     
    Japan  

     

    3,060

     

     

    114

     

     

    -

     

     

    3,174

       

     

    2,999

     

    2.0

       

    5.8

     
    Total Revenue  

    $

    125,342

     

    $

    (399)

     

    $

    (8,751)

     

    $

    116,192

       

    $

    107,504

     

    16.6

    %  

    8.1

    %
                         
                         
      Nine Months Ended
    September 30, 2021
        Nine Months Ended
    September 30, 2020
      %      
      GAAP  

    Foreign

    Currency1

     

    Hubs

    Acquisition2

      Non-GAAP     GAAP   Change3    

    %

    Change

    Organic4

     
    Revenues                    
    United States  

    $

    286,524

     

    $

    -

     

    $

    (12,512)

     

    $

    274,012

       

    $

    262,507

     

    9.1

    %  

    4.4

    %
    Europe  

     

    68,259

     

     

    (3,986)

     

     

    (10,942)

     

     

    53,331

       

     

    56,413

     

    21.0

       

    (5.5)

     
    Japan  

     

    9,733

     

     

    83

     

     

    -

     

     

    9,816

       

     

    10,267

     

    (5.2)

       

    (4.4)

     
    Total Revenue  

    $

    364,516

     

    $

    (3,903)

     

    $

    (23,454)

     

    $

    337,159

       

    $

    329,187

     

    10.7

    %  

    2.4

    %
                         
    1 Revenue for the three and nine-month periods ended September 30, 2021 has been recalculated using 2020 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
    2 Revenue for the three and nine-month periods ended September 30, 2021 has been recalculated to exclude revenue earned from our acquisition of Hubs, Inc. to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions.
    3 This column presents the percentage change from GAAP revenue for the three and nine-month periods ended September 30, 2020 to GAAP revenue for the three and nine-month periods ended September 30, 2021.
    4 This column presents the percentage change from GAAP revenue for the three and nine-month periods ended September 30, 2020 to non-GAAP revenue for the three and nine-month periods ended September 30, 2021 (as recalculated using the foreign currency exchange rates in effect during the three- and nine-month periods ended September 30, 2020, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison.
    Proto Labs, Inc.
    Product Developer Information
    (Unaudited)
       
      Three Months Ended Nine Months Ended
      September 30, September 30,
     

    2021

    2020

    2021

    2020

    Unique product developers and engineers served  

    23,457

    18,796

    49,300

    37,504

       

     




    Business Wire (engl.)
    0 Follower
    Autor folgen

    Protolabs Reports Financial Results for the Third Quarter of 2021 Proto Labs, Inc. (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights include: Revenue for the third quarter of …

    Schreibe Deinen Kommentar

    Disclaimer